Thermal Science and Engineering

Nanoparticles for Magnetic Hyperthermia

Submission deadline: 2023-10-31
Special Issue Editors

Special Issue Information

Planned Papers

Dear Colleagues,

Magnetic hyperthermia (MH) is one of the finest clinical approach for cancer therapy. MH employs local heat produced in the tumor area by an external alternating magnetic field to destruction of cancer cells and, in some protocols, to advance the effects of radiotherapy and chemotherapy. For instance, structural and magnetic properties of magnetic nanoparticles, coatings materials of different shape and compositions have been developed subjected to the tumor type and area. Moreover, the result of an MH experiment is extremely affected by numerous variables, but are still inadequate when establishing new MH studies for broad range cancer applications. In this context, besides new magnetic nanomaterials with various sizes, shapes and compositions to extensively develop the local heating (micro/nanoscale) for selectively annihilation of tumor cells/intracellular structures, also novel methods and configurations are being explored to enhance the therapeutics. These include multimodal therapy, which is the combination of MH with chemotherapy, radiotherapy, immunotherapy, photodynamic or phototherapy. These optimized magnetic nanomaterials and related processes are still needed to be extensively investigated for various medical applications. This Special issue provides an opportunity for the most recent advances in Nanoparticles for Magnetic hyperthermia and their related phenomena. Submissions are expected in relation to the development of novel magnetic materials and design of multimodal therapy for bio-medical applications.


Keywords

Magnetic Nanoparticles; Magnetic Hyperthermia; Local Heating; Cancer Therapy; Nanohybrids; Multimodal Therapy; Saturation Magnetization; Controlled Local Thermia; Early Diagnostics; On Chip Devices

Published Paper